Explore the Potential with AI-Driven Innovation
This extensive focused library is tailor-made using the latest virtual screening and parameter assessment technology, operated by the Receptor.AI drug discovery platform. This technique is more effective than traditional methods, offering compounds with improved activity, selectivity, and safety.
We carefully select specific compounds from a vast collection of over 60 billion molecules in virtual chemical space. Our partner Reaxense helps in synthesizing and delivering these compounds.
The library features a range of promising modulators, each detailed with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Plus, each compound is presented with its ideal docking poses, affinity scores, and activity scores, ensuring a thorough insight.
We employ our advanced, specialised process to create targeted libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
It includes comprehensive molecular simulations of the catalytic and allosteric binding pockets and the ensemble virtual screening accounting for their conformational mobility. In the case of designing modulators, the structural changes induced by reaction intermediates are taken into account to leverage activity and selectivity.
Key features that set our library apart include:
partner
Reaxense
upacc
P03905
UPID:
NU4M_HUMAN
Alternative names:
NADH dehydrogenase subunit 4
Alternative UPACC:
P03905; Q6RL39; Q6RQN9; Q8HNR8
Background:
NADH-ubiquinone oxidoreductase chain 4, also known as NADH dehydrogenase subunit 4, plays a pivotal role in cellular energy production. It is a core component of the mitochondrial membrane respiratory chain Complex I, essential for electron transfer from NADH to ubiquinone, facilitating ATP synthesis.
Therapeutic significance:
This protein's malfunction is linked to severe mitochondrial disorders, including Leber hereditary optic neuropathy and mitochondrial encephalomyopathy. Understanding its function could lead to breakthroughs in treating these energy-production-related diseases.